Your browser version may not work well with NCBI's Web applications. More information here...
1: Control Clin Trials. 2004 Apr;25(2):203-22.Links

Implementation of the Prostate Cancer Prevention Trial (PCPT).

Goodman PJ, Tangen CM, Crowley JJ, Carlin SM, Ryan A, Coltman CA Jr, Ford LG, Thompson IM.

Southwest Oncology Group Statistical Center, M/S M3-C102, 1100 Fairview Avenue North, Box 19024, Seattle, WA 98109-1024, USA. pgoodman@fhcrc.org

The Prostate Cancer Prevention Trial is a randomized double blind chemoprevention trial of 18,882 men. It is designed to test the difference in the histologically proven prostate cancer prevalence between a group of participants given finasteride and another given placebo for 7 years. We present an overview of the study design, details of the administrative structure of the study and a description of the successful implementation of the accrual phase.

PMID: 15020037 [PubMed - indexed for MEDLINE]

Related Articles

Patient Drug Information
  • Finasteride (Proscar®) Finasteride is used alone or in combination with other medications to treat benign prostatic hypertrophy (BPH, enlargement of the prostate gland). Finasteride improves symptoms of BPH such as frequent and difficult urina...
    » read more ...